Psyched Wellness Signs Two Year Supply Agreement For Amanita Muscaria

Psyched Wellness (CSE: PSYC) this morning had a brief announcement. Within, the company revealed that it has entered into a supply agreement for Amanita Muscaria, the functional mushroom in which it has focused its research efforts.

The supply agreement has been entered into with that of MB MEMEL GOODS, a firm based in Lithuania that is focused on gathering, processing, and distributing numerous wild mushrooms. Under the terms of the arrangement, an initial 200 kilograms of amanita muscaria dried mushroom caps are to be supplied to Psyched.

Initial shipments under the arrangement are expected to begin in September, and continue on a monthly basis through December 2021. Psyched will then use the dried mushroom caps to create its AME-1 extract.

Selkirk Copper Mines — sponsored Sponsored · Selkirk Copper Mines

The supply agreement is valid for a period of two years.

Psyched Wellness last traded at $0.28 on the CSE.


FULL DISCLOSURE: Psyched Wellness is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Psyched Wellness on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Seabridge Loses KSM’s Substantially Started Status

This Gold Giant Got Crushed… Now It’s the Cheapest Major | Kinross Gold’s Q3 Earnings

Why I’m Still Bullish on Gold Below $3,900 | Wes Hanson – Thunder Gold

Recommended

Epic Gold Delivers Maiden 279,000 Ounce Inferred Resource at Wilson Project

First Phosphate Adds UK Export Finance to Growing Export Credit Lineup With C$220 Million Letter of Interest

Related News

Psyched Wellness Latest Firm To Conduct Bought Deal Financing

Psyched Wellness (CSE: PSYC) is the latest psychedelics-focused firm to announce a bought deal financing,...

Thursday, January 21, 2021, 07:53:05 PM

Psyched Wellness Completes Extraction Protocol For First Mushroom Products

Psyched Wellness (CSE: PSYC) has completed a number of milestones with regards to getting its...

Thursday, December 10, 2020, 07:45:56 AM

Psyched Wellness Raises $6.6 Million In Bought Deal Financing

Psyched Wellness (CSE: PSYC) has closed its previously announced private placement. The company managed to...

Wednesday, February 17, 2021, 11:38:02 AM

Psyched Wellness To Conduct Stability Tests On Proprietary Mushroom Extract

Psyched Wellness (CSE: PSYC) is progressing with the development of its flagship product, an extract...

Monday, July 26, 2021, 09:28:00 AM

Psyched Wellness Completes 14 Day Oral Toxicity Preclinical Study For Proprietary Extract

Psyched Wellness (CSE: PSYC) this morning announced the results of its initial 14-day oral toxicity...

Tuesday, July 6, 2021, 08:58:10 AM